Evidence map›Paper›PMID 33460566›Full record

ArticleThe Lancet. Infectious diseases2021

Long COVID in the skin: a registry analysis of COVID-19 dermatological duration.

Devon E McMahon, Antonia E Gallman, George J Hruza, Misha Rosenbach, Jules B Lipoff, Seemal R Desai, Lars E French, Henry Lim, Jason G Cyster, Lindy P Fox and 2 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05587868 (Karakteristik Dan Pengaruh Vaksinasi COVID-19 Terhadap Klinis Dan Kualitas Hidup Pasien Long COVID di RSUPN Dr. Cipto Mangunkusumo), which is not on this map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05587868 unknown statusnot on this mapstarted 2022, after this paper: background citation

Karakteristik Dan Pengaruh Vaksinasi COVID-19 Terhadap Klinis Dan Kualitas Hidup Pasien Long COVID di RSUPN Dr. Cipto Mangunkusumo

TypeobservationalSponsorIndonesia UniversityRan2022 to 2023Enrolled250ConditionsCOVID-19, SARS CoV-2 InfectionArmsCOVID-19 Vaccine
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Post-COVID-19 Syndrome Mechanisms, Prevention and Management.International journal of preventive medicine · 2023
    Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Devon E McMahonDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Antonia E GallmanDepartment of Dermatology, University of California San Francisco, San Francisco, CA, USA; Department of Immunology and Microbiology, University of California San Francisco, San Francisco, CA, USA.
George J HruzaDepartment of Dermatology, St Louis University, St Louis, MO, USA.
Misha RosenbachDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
Jules B LipoffDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
Seemal R DesaiDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Lars E FrenchDepartment of Dermatology, University of Texas Southwestern & Innovative Dermatology, Dallas, TX, USA.
Henry LimDepartment of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany; Department of Dermatology, Henry Ford Health System, Detroit, MI, USA.
Jason G CysterDepartment of Immunology and Microbiology, University of California San Francisco, San Francisco, CA, USA.
Lindy P FoxDepartment of Dermatology, University of California San Francisco, San Francisco, CA, USA.
Marlys S FassettDepartment of Dermatology, University of California San Francisco, San Francisco, CA, USA; Department of Immunology and Microbiology, University of California San Francisco, San Francisco, CA, USA.
Esther E FreemanDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, MA, USA. Electronic address: efreeman@mgh.harvard.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
NIGMS NIH HHS T32 GM007618
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultCOVID-19FemaleHumansMaleMiddle AgedSARS-CoV-2SkinSkin DiseasesYoung Adult

Identifiers

PMID33460566
PMCPMC7836995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.